A novel splice-acceptor site mutation (IVS13-2A>T) of polycystic kidney disease 1 (PKD1) gene resulting in an RNA processing defect with a 74-nucleotide deletion in exon 14 of the mRNA transcript

Autosomal dominant polycystic kidney disease (ADPKD) occurs mainly from mutations of polycystic kidney disease 1 (PKD1) gene. A novel mutation of the PKD1 gene due to a nucleotide substitution in splice‐acceptor site of IVS13 (AG‐>TG) was identified by analyses of PKD1‐cDNA and genomic DNA. The IVS13‐2A>T substitution resulted in an inactivation of this splice site and utilization of cryptic splice acceptor site in exon 14, causing a 74‐nucleotide deletion of this exon in the PKD1‐mRNA transcript. The abnormal transcript was present ectopically in the patients' lymphocytes. The partial deletion of PKD1‐mRNA leads to frameshift translation and introduces a termination signal at codon 1075. The truncated protein with about one quarter of the full‐length polycystin‐1 is most likely inactive. Thus, the effect of this mutation would be “loss‐of‐function” type. Allele specific amplification (ASA) was developed to detect the mutation in DNA samples of other family members. The mutation was present in 11 affected but absent in 13 unaffected family members, corresponding to the results of linkage analysis. In addition, it was not observed in DNA samples of 57 unrelated healthy individuals. Hum Mutat 15:115, 2000. © 2000 Wiley‐Liss, Inc.